Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 56 pembrolizumab 50 Cisplatin 43 Magnetic Resonance Spectroscopy 27 enfortumab vedotin 22 Specimen Handling 22 Nivolumab 22 Cystectomy 18 durvalumab 16 Carboplatin 16 avelumab 15 Mitomycin 14 atezolizumab 13 Docetaxel 13 Cystoscopy 12 Fluorouracil 11 Radiation 9 Transurethral Resection of Bladder 8 Radiotherapy 8 Ipilimumab 8 sacituzumab govitecan 7 Standard of Care 7 Radiosurgery 7 Paclitaxel 7 Immunoglobulin G 7 Disulfides 7 erdafitinib 6 cemiplimab 6 Surveys and Questionnaires 6 Surgical Procedures, Operative 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Circulating Tumor DNA × 1 year × Clear all

NCT06537154 2025-07-30

NEO-BLAST

University of British Columbia

Phase 2/3 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡